Approve more Covid vaccines, expand vaccination based on need: Sonia to PM

This comes amid a surge in coronavirus cases in the country

Congress interim president Sonia Gandhi
Congress interim president Sonia Gandhi
Press Trust of India New Delhi
2 min read Last Updated : Apr 12 2021 | 8:05 PM IST

Amid a surge in coronavirus cases in the country, Congress president Sonia Gandhi has requested Prime Minister Narendra Modi to allow emergency use of all the vaccine candidates having required clearances.

In a letter to the prime minister after her meeting with chief ministers of Congress-ruled states, she also sought expansion of categories of people eligible for vaccination on the basis of need and exposure rather than age.

"While it will be necessary on one hand to substantially ramp up our domestic production capacity, it will also be prudent to allow emergency use authorisation of all the vaccine candidates that have the required clearances, without any further delay," she told the prime minister in her letter.

"Accordingly, with enhanced availability, categories eligible for vaccination should be expanded on the basis of need and exposure rather than just age. In the same vein, the numbers allocated to a state has to be based on the prevalence and projection of infection in that particular state," she said, noting that some states have vaccines for three to five days left.

The Congress chief appealed to the prime minister that with restrictions being imposed to stop the spread of the virus, he should put in place a minimum monthly guaranteed income scheme and transfer a sum of Rs 6,000 into every eligible citizen's account.

She also called for exemption from Goods and Services Tax (GST) for all equipment, instruments, medicines being used in the fight against the COVID-19 pandemic.

India hit a new coronavirus infection record with 1,68,912 new cases, the highest single-day rise so far, taking the total tally of cases to 1,35,27,717, according to data updated by the Union Health Ministry on Monday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Apr 12 2021 | 8:03 PM IST

Next Story